# PREGABALIN
> **ANDA214496** · Abbreviated New Drug Application (Generic) · Sponsor: EPIC PHARMA LLC · Approved 2023-06-01
## Drug
- **FDA Application Number:** ANDA214496
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREGABALIN
- **Generic name:** Pregabalin
- **Active ingredients:** PREGABALIN
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EPIC PHARMA LLC
- **First approval:** 2023-06-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214496)
---
*MORVS · CC0 1.0*